Match tier Listed
Presence Current · Arkansas
Last published 2026
Sources OpenAlex · ORCID
Refreshed 2026-08-15

Samir V. Jenkins

High Impact

Researcher

Also affiliated: United States Food and Drug Administration (2015); Cornell University (2019); Yale University (2008); Sterling Research Group (2008); Radiation Oncology Institute (2023); Winthrop Rockefeller Foundation (2019–2025); ORCID (2020); Radiation Oncology Associates (2023)

Faculty Researcher

21 h-index 75 pubs 1,440 cited

  • Humans
  • Animals
  • Mice
  • Gold
  • Metal Nanoparticles
  • Cell Line, Tumor
  • Nanoparticles
  • Lung Neoplasms
  • Mice, Inbred BALB C
  • Neoplasms
  • Phototherapy
  • Antineoplastic Agents
  • Anti-Bacterial Agents
  • Radiation Tolerance
  • Neovascularization, Pathologic

Biography and Research Information

OverviewAI-generated summary

Samir V. Jenkins' research focuses on the application of nanomaterials in therapeutic and diagnostic contexts, particularly in cancer treatment. His work investigates the photothermal properties of gold nanostructures and their conversion into self-assembled ionic nanomaterials for enhanced therapeutic effects. Jenkins has explored the use of nanocage-coated artificial extracellular matrices to promote neural stem cell differentiation and the nanoscale control of photothermal action in gold nanostructure-coated surfaces.

His research also extends to drug delivery systems, including liposome formulations for tumor-targeted delivery in conjunction with radiation therapy. Jenkins has examined the molecular mechanisms underlying cancer progression and dormancy, including the role of specific proteins in inducing reversible dormancy in lung tumor cells and the exosomal profiles of hepatocellular carcinoma cells. He has also investigated bystander effects in spatially fractionated radiation therapy and the proinflammatory activity of VEGF-targeted treatments.

Jenkins leads a research group and collaborates with researchers at the University of Arkansas for Medical Sciences, including Ruud P.M. Dings, Robert Griffin, and Azemat Jamshidi‐Parsian, as well as Narasimhan Rajaram at the University of Arkansas at Fayetteville. His scholarly output is characterized by a high h-index of 21 and over 1,400 citations across 75 publications, designating him as a highly cited researcher.

Metrics

  • h-index: 21
  • Publications: 75
  • Citations: 1,440

Selected Publications

  • Synthesis of Peptide Analogs From Fish Venom With Potential Antimicrobial and Anticancer Activity (2026)
    Chemical Biology & Drug Design DOI OpenAlex
  • Abstract 4785: Thermal regulation of dysbiotic tumor vasculature (2026)
    Cancer Research DOI OpenAlex
  • Modified tumor uptake and biodistribution of nanoparticles coated with small extracellular vesicle membranes derived from distinct tumor cell lines (2026)
    International Journal of Hyperthermia DOI OpenAlex
  • CB-839 induces reversible dormancy in lung tumor-cells (2024)
    European Journal of Pharmacology 8 citations DOI OpenAlex
  • Interrogating the Role of Endocytosis Pathway and Organelle Trafficking for Doxorubicin-Based Combination Ionic Nanomedicines (2024)
    ACS Applied Bio Materials 6 citations DOI OpenAlex
  • Bystander Effects in Spatially Fractionated Radiation Therapy: From Molecule To Organism To Clinical Implications (2024)
    Seminars in Radiation Oncology 13 citations DOI OpenAlex
  • Abstract 186: Tumor exosome-macrophage interactions: The role of tumor-associated glycans and scavenger receptor class A (2024)
    Cancer Research DOI OpenAlex
  • Morphological Effects and In Vitro Biological Mechanisms of Radiation-Induced Cell Killing by Gold Nanomaterials (2023)
    ACS Applied Materials & Interfaces 2 citations DOI OpenAlex
  • Exosomal MicroRNA and Protein Profiles of Hepatitis B Virus-Related Hepatocellular Carcinoma Cells (2023)
    International Journal of Molecular Sciences 12 citations DOI OpenAlex
  • General principles of SFRT biology (2023)
  • Proteomic analysis of transcription factors involved in the alteration of ischemic mouse heart as modulated by MSC exosomes (2023)
    Biochemistry and Biophysics Reports 1 citation DOI OpenAlex
  • Supplemental Figures 1-9 and Table S1 from Gastrointestinal Tract Dysbiosis Enhances Distal Tumor Progression through Suppression of Leukocyte Trafficking (2023)
  • Supplemental Figures 1-9 and Table S1 from Gastrointestinal Tract Dysbiosis Enhances Distal Tumor Progression through Suppression of Leukocyte Trafficking (2023)
  • Proteomic Analysis of Transcription Factors Involved in the Alteration of Ischemic Mouse Heart as Modulated by MSC Exosomes (2023)
    SSRN Electronic Journal 1 citation DOI OpenAlex
  • Proinflammatory activity of VEGF-targeted treatment through reversal of tumor endothelial cell anergy (2022)
    Angiogenesis 54 citations DOI OpenAlex

View all publications on OpenAlex →

Collaboration Network

96 Collaborators 24 Institutions 3 Countries

Top Collaborators

View profile →
View profile →
View profile →
View profile →
View profile →

Similar Researchers

Based on overlapping research topics